Results

Total Results: 785 records

Showing results for "prescribing".

  1. effectivehealthcare.ahrq.gov/sites/default/files/cer-215-depression-older-adults-comments.pdf
    March 28, 2019 - concept is used in multiple contexts with differing definitions and sometimes is used to indicate prescribing … I fear the results of reviews such as this contribute to fear of prescribing among primary care physicians … consideration in the context of the individual patient before relying on this comparative harms data to make prescribing … Resulting drug-drug interactions and pharmacokinetic changes must be taken into consideration when prescribing
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
    March 28, 2019 - concept is used in multiple contexts with differing definitions and sometimes is used to indicate prescribing … I fear the results of reviews such as this contribute to fear of prescribing among primary care physicians … consideration in the context of the individual patient before relying on this comparative harms data to make prescribing … Resulting drug-drug interactions and pharmacokinetic changes must be taken into consideration when prescribing
  3. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - abdominal pain.38 Other adverse events associated with azithromycin that could dissuade a physician from prescribing … KALYDECO (ivacaftor) tablets prescribing information. [internet]. … Zithromax (azithromycin tablets) and (azithromycin for oral suspension) prescribing information. … http://www.onlinepharmacycatalog.com/drugs-medications/antibiotics/azithromycin/zithromax-prescribing-information.pdf … http://www.onlinepharmacycatalog.com/drugs-medications/antibiotics/azithromycin/zithromax-prescribing-information.pdf
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-acute-pain.xlsx
    September 21, 2022 - Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-acute-pain.xlsx
    September 20, 2022 - Results, Function Results, QOL and Satisfaction with Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
    January 01, 2007 - A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing … or problems) 55.0 5.6 Physician consultation (contact with the patient’s primary care or other prescribing … Therapy tools and/or education for physicians (provision of patient-specific reports, physician prescribing
  7. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-including-both-children-and-adult-subgroup-comparisons-with-type-1-diabetes-what-is-the-comparitive-differences-in-hba1c-levels-when-comparing-various-treatment-options-including-multiple-daily-injections-insulin
    July 19, 2009 - The variations in clinical care - prescribing an insulin pump for a blind person who has type 2 diabetes
  8. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - Pricing, reimbursement, and prescribing barriers have been the priority for the manufacturers of lorcaserin … The recommended prescribing by the manufacturer includes an initial low-titration dosage and a mid-titration … Drug Enforcement Administration as a Schedule IV drug; it became available for prescribing in June … IV drug (i.e., with a low potential for abuse and low risk of dependence); it became available for prescribingPrescribing information for Belviq (lorcaserin hydrochloride) tablets. [internet].
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-d-surveillance-report-1.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study design Duration Setting Country Eligibility criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due To Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…
  11. effectivehealthcare.ahrq.gov/sites/default/files/cer-218-osteoporosis-disposition-comments.pdf
    April 23, 2019 - appropriate to list anti-sclerostin monoclonal antibody class-specific harms in Table 3 when the final prescribingPrescribing Information, (06/2018). Cummings SR, Ferrari S, Eastell R et al. … I suggest that the committee carefully review the FDA-approved Prescribing Information for each product … Prescribing Information, (06/2018). 2Miller PD, Bolognese MA, Lew iecki EM et al. … Prescribing Information, (06/2018).
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
    April 23, 2019 - appropriate to list anti-sclerostin monoclonal antibody class-specific harms in Table 3 when the final prescribingPrescribing Information, (06/2018). Cummings SR, Ferrari S, Eastell R et al. … I suggest that the committee carefully review the FDA-approved Prescribing Information for each product … Prescribing Information, (06/2018). 2Miller PD, Bolognese MA, Lew iecki EM et al. … Prescribing Information, (06/2018).
  13. effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/research-protocol
    April 26, 2013 - treatment, less than 1 in 10 receives medication as part of his or her treatment, which leads to a prescribing … Very low prescribing rates for these medications indicate that primary care providers are rarely using … Although primary care providers are proficient at prescribing a wide variety of medications, they generally … of subject recruitment), interventions (e.g., dose and frequency of administration; type of provider prescribing … of enrolled populations; co-occurring disorders of enrolled populations; setting; type of provider prescribing
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
    January 27, 2012 - treatment, less than 1 in 10 receives medication as part of his or her treatment, which leads to a prescribing … Very low prescribing rates for these medications indicate that primary care providers are rarely using … Although primary care providers are proficient at prescribing a wide variety of medications, they generally … subject recruitment), interventions (e.g., dose and frequency of administration; type of provider prescribing … of enrolled populations; co-occurring disorders of enrolled populations; setting; type of provider prescribing
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
    February 01, 2016 - Clinical Bottom Line (Continued) ALDH2 = aldehyde dehydrogenase 2 c The prescribing information sheet … Clinicians are advised to refer to the prescribing information sheet for additional information on adverse
  16. effectivehealthcare.ahrq.gov/products/migraine-treatments/protocol
    January 08, 2020 - What are the effects of prescribing opioid therapy versus not prescribing opioid therapy for acute episodic
  17. effectivehealthcare.ahrq.gov/products/opioid-use-disorder/research-protocol
    February 29, 2016 - increase from 2001). 4 These trends have occurred in conjunction with markedly increased rates of opioid prescribing
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-use-disorder_research-protocol.pdf
    February 24, 2016 - increase from 2001).4 These trends have occurred in conjunction with markedly increased rates of opioid prescribing
  19. effectivehealthcare.ahrq.gov/products/medicare-medication-use/research
    April 23, 2014 - Data Points #19: Medication Use in Medicare Research Report April 23, 2014 Web Version [NLM Site] Download Main Document PDF 797.2 KB People using assistive technology may not be able to fully access information in these files. For additional assistance, please contact us . This report is from AHRQ's…
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0371_11-23-2010.pdf
    January 01, 2010 - Effective Health Care Topic Number: 0313 Document Completion Date: 12-12-11 1 Results of Topic Selection Process & Next Steps  Outcomes of serious mental illness will go forward for refinement as a systematic review. The scope of this topic, including populations, interventions, comparators, and…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: